Bifogade filer
PDF
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Bioteknik |
In a court ruling by the Supreme Administrative Court on the 2 of October 2025, the court ruled in favour of Bio-Works Technologies AB's against the Swedish Tax Agency. The tax surcharge of 2,0 MSEK has been removed (nullified) and the amount has now been reimbursed to Bio-Works Technologies AB, with interest, i.e. Bio-Works cash position increases with 2,1 MSEK.
The Swedish Tax Agency decided on a tax surcharge of 2.0 MSEK for Bio-Works Technologies AB in 2022. The appeals have been ongoing since then and the Administrative Court of Appeals in Stockholm delivered their verdict on the 25th of March 2024. The Supreme Administrative Court has now changed the verdict of the Court of Appeals. Since the resolution of the appeal was uncertain, the tax surcharge was recognized as an expense in the 2023 Annual Report and paid to the Swedish Tax Agency during 2024.
Contacts
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Arne Hauge, CFO, e-mail: arne.hauge@bio-works.com, phone: +46(0)8-502 705 83.
About Bio-Works
Bio-Works enables Biotech companies to achieve their goals for purification of biomolecules. We support our customers, from laboratory research to commercial production, and together we implement efficient and robust solutions for bioprocessing. Our ambition is to be a trusted and dynamic partner in an industry characterized by growth and development.
Bio-Works' headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Spotlight Stock Market ("BIOWKS"). For more information, visit www.bio-works.com.